ABBV-951
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for ABBV-951, covering 2022-11-18 to 2025-12-24. Get the full timeline:
Most recent: Clinical Trial Update: Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's Disease